Measuring the benefits of treatment.
The efficacy of the authors
Bowen therapy is evaluated by comparing the number of treatments vis-à-vis
the patients perceived benefit from those treatments.
The Patients response.
The response has been graded from
One to Five.
- One, is slight or no apparent
- Two, is some benefit, but the
patient either stopped having treatment, (often without giving a reason),
or NHS treatment suddenly became available.
- Three, is some relief from the
condition, but further treatment not taken up or deferred.
- Four, is considerable benefit
but some intermittent low-level discomfort, (usually with self-healing
- Five, the condition cleared.
Each block represents the patients
response. The horizontal axis shows the number of treatments to give that
response. The vertical axis shows the number of patients per column. The
chart enables a patient to be tracked through the system.
The numbers in the squares refer to the patients case number.
Some case notes are numbered with
a suffix a, b, or, c. This means that
the patient had additional treatment at least three months after the preceding
one. Usually this is because of either re-injury, a new condition, or
that they declined a second recommended follow-on treatment and had to
come back later.
Patients numbered 1 to 22 were case
studies treated during the one years-training period. The associated chart
shows the correlation between the number of treatments and the benefit.
Analysis of the chart.
Response 1. 3 people, ( 3.15%).
Response 2. 10 people, (10.5%). Response 3. 15 people, (15.8%). Response
4. 34 people, (35.8%). Response 5. 33 people, (34.7%).
Taking Responses 4 and 5 as desirable,
then 70.5% of patients had a satisfactory conclusion. Further analysis
of Responses 4 and 5 show that one treatment benefited 23 people, (24.2%);
two treatments, benefited 44 people, (46.3%); and three treatments (the
recommended minimum), benefited 60 people, (63.2%). Four or more treatments,
(which only 6 people needed), benefited 67 people, (70.5%)
Comments about the chart.
The figures above would have been
improved if there had been included unrelated conditions that had been
alleviated during the treatments, and the dozen or so mini
treatments applied at open days that gave people immediate
Also included are patients, who
contrary to advice given, mixed therapies, not kept the second appointment,
and not having the courtesy to return calls enquiring about their reaction
to the treatment. What is even more remarkable about the figures is that
Bowen therapy, due to a general lack of awareness, is a call of last resort
for people who have found that nothing else has worked for them. The figures,
even on the relatively small sample, and including cases undertaken whilst
not fully trained, show that Bowen therapy has a lot to offer, and could
make it one of the first-choice options in the future.